Celsius (NASDAQ:CELH – Free Report) had its price target reduced by B. Riley from $50.00 to $47.00 in a research note published on Monday, Benzinga reports. They currently have a buy rating on the stock. B. Riley also issued estimates for Celsius’ Q3 2024 earnings at $0.02 EPS, FY2024 earnings at $0.65 EPS, FY2025 earnings at $0.71 EPS and FY2026 earnings at $1.09 EPS.
Other equities research analysts have also recently issued research reports about the company. Bank of America decreased their target price on Celsius from $32.00 to $26.00 and set an “underperform” rating for the company in a research note on Thursday, September 5th. Maxim Group lowered their price objective on shares of Celsius from $65.00 to $50.00 and set a “buy” rating for the company in a research note on Thursday, September 5th. Stifel Nicolaus cut their target price on shares of Celsius from $61.00 to $51.00 and set a “buy” rating on the stock in a research note on Thursday, September 5th. LADENBURG THALM/SH SH decreased their price target on shares of Celsius from $72.00 to $68.00 and set a “neutral” rating for the company in a research note on Monday, October 21st. Finally, Piper Sandler dropped their price objective on shares of Celsius from $50.00 to $47.00 and set an “overweight” rating on the stock in a report on Tuesday, September 24th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $56.27.
Get Our Latest Analysis on CELH
Celsius Stock Performance
Celsius (NASDAQ:CELH – Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.05. Celsius had a net margin of 19.58% and a return on equity of 94.75%. The business had revenue of $402.00 million for the quarter, compared to analysts’ expectations of $391.07 million. During the same quarter in the prior year, the firm posted $0.17 earnings per share. The business’s quarterly revenue was up 23.4% compared to the same quarter last year. Analysts forecast that Celsius will post 0.79 earnings per share for the current year.
Insider Activity at Celsius
In other Celsius news, CEO John Fieldly sold 74,847 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $32.80, for a total transaction of $2,454,981.60. Following the transaction, the chief executive officer now directly owns 1,812,490 shares in the company, valued at approximately $59,449,672. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.20% of the stock is owned by insiders.
Institutional Trading of Celsius
A number of hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. increased its position in shares of Celsius by 18.7% during the 1st quarter. Vanguard Group Inc. now owns 16,313,762 shares of the company’s stock valued at $1,352,737,000 after purchasing an additional 2,567,290 shares during the last quarter. Capital International Investors increased its holdings in Celsius by 50.6% during the first quarter. Capital International Investors now owns 3,966,194 shares of the company’s stock worth $328,877,000 after buying an additional 1,333,217 shares during the last quarter. Massachusetts Financial Services Co. MA raised its position in Celsius by 231.2% in the second quarter. Massachusetts Financial Services Co. MA now owns 3,946,208 shares of the company’s stock worth $225,289,000 after acquiring an additional 2,754,722 shares during the period. Bank of New York Mellon Corp boosted its stake in Celsius by 36.7% in the second quarter. Bank of New York Mellon Corp now owns 2,942,433 shares of the company’s stock valued at $167,983,000 after acquiring an additional 790,014 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Celsius by 0.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,802,264 shares of the company’s stock valued at $232,365,000 after acquiring an additional 9,054 shares during the period. 60.95% of the stock is currently owned by institutional investors.
About Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
See Also
- Five stocks we like better than Celsius
- Pros And Cons Of Monthly Dividend Stocks
- Rise of AI Agents vs. RPA Bots: 3 Stocks to Watch Now
- How to Read Stock Charts for Beginners
- Merck vs. Bristol-Myers: Analyst Views Differ After Q3 Earnings
- Breakout Stocks: What They Are and How to Identify Them
- Intel: Is Now the Time to Be Brave?
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.